Response to lupus treatment escalation was low overall and lowest in Black patients

Design

Longitudinal register cohort, 64 UK centres

Population

422 people with active moderate-to-severe SLE starting escalated therapy

Primary outcome

Major clinical response at 6 and 12 months

Effect

23% overall at 12 months; Black vs White adjusted OR 0.13 (0.02–0.88)

This longitudinal cohort used the British Isles Lupus Assessment Group Biologics Register across 64 UK centres. It included 422 people aged 16 or over with active moderate-to-severe lupus who had started rituximab or belimumab within a year, or standard immunosuppression within a month. The primary outcome was major clinical response at 6 and 12 months.

At 12 months, 23% met major clinical response criteria. Response was 42% in East Asian, 30% in South Asian, 24% in White and 10% in Black patients. Black patients started with higher disease activity, more organ damage and more comorbidity, and after adjustment had much lower odds of response than White patients (OR 0.13, 95% CI 0.02–0.88).

Two messages matter. First, escalation achieves major response in only a minority within a year, so expectations and steroid-sparing plans should be realistic. Second, South Asian patients — the group closest to Indian practice — did at least as well as White patients here, but numbers were small and these are UK data.

• Set realistic expectations: most patients did not reach major response within a year of escalation
• Review steroid dose and adherence at each visit after escalation
• Assess baseline damage and comorbidity, which differ by ethnicity and affect response
• Consider earlier escalation or combination strategies when response is slow
• Encourage participation in trials to widen the evidence base across ethnic groups

Why it matters

Challenges the assumption that escalation to a biologic will usually bring lupus under control within a year.

Don't overread it

Observational register data with small subgroups; it does not show ethnicity itself causes poorer response.

The statistics, in plain English

An odds ratio of 0.13 means much lower odds of response for Black patients, but the confidence interval from 0.02 to 0.88 is very wide, reflecting only seven responders in that group. The direction is clear; the size is uncertain.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.